bpc-157 fda compounding category Advisory Committee Recommends Adding to List This is the first vote

This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make FDA removes BPC 157, KPV, Semax from Category 2 on April 22 but they are not legal to compound yet PeptideKnow FDA panel votes to place popular peptide BPC 157 on compounding list Reuters BPC 157 Legal Status: FDA Regulations and Compounding This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change

SKU: 58290158528 · From lagence-mr.com